RODRIGO SOUZA
Biocatalysis and Organic Synthesis Group, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazils

In 2022 FDA approved 37 new drugs for the treatment of various diseases, including small, medium, and biological molecules. Some of these drugs or the combination between one or two molecules have never been used in clinical practice, including NME (New Molecular Entities) and NCE (New Chemical Entities). Others are the same as, or related to, previously approved drugs, and they will compete in the market. The infographic below shows the small molecules approved in 2022 and in the next issues we will cover the approved drugs for 2023.

ABOUT THE AUTHOR

Rodrigo Souza - Since I started my independent career, I have pursuit the development of new technologies to guide research by innovative ideas. We have been working at Federal University of Rio de Janeiro on the establishment of continuous flow technology for active pharmaceutical ingredients (API) synthesis in Brazil, showing that is possible to reduce costs on prod ... ... ...